Tissue Inhibitor of Metalloproteinase-1
-
Subject Areas on Research
-
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
-
Association between ratio of matrix metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
-
Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
-
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
-
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
-
Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium.
-
Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions.
-
Endothelial Cell-Derived Extracellular Vesicles Mitigate Radiation-Induced Hematopoietic Injury.
-
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
-
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
-
Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells.
-
Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord.
-
Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1.
-
Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.
-
Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma.
-
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
-
Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
-
Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.
-
Molecular phenotypes of notochordal cells purified from immature nucleus pulposus.
-
Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways.
-
Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
-
Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1.
-
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.
-
Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes.
-
STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
-
Selenium's effects on MMP-2 and TIMP-1 secretion by human trabecular meshwork cells.
-
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
-
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.
-
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.
-
Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.
-
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.
-
[The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance].